Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Akso Health (AHG) Current Deferred Revenue (2019 - 2025)

Akso Health (AHG) has disclosed Current Deferred Revenue for 4 consecutive years, with $415020.0 as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Current Deferred Revenue rose 113.51% year-over-year to $415020.0, compared with a TTM value of $415020.0 through Mar 2024, up 113.51%, and an annual FY2024 reading of $415020.0, up 113.51% over the prior year.
  • Current Deferred Revenue was $415020.0 for Q1 2024 at Akso Health, up from $194376.0 in the prior quarter.
  • Across five years, Current Deferred Revenue topped out at $415020.0 in Q1 2024 and bottomed at $124682.0 in Q1 2020.
  • Average Current Deferred Revenue over 3 years is $244692.7, with a median of $194376.0 recorded in 2023.
  • The sharpest move saw Current Deferred Revenue grew 12.6% in 2020, then soared 113.51% in 2024.
  • Year by year, Current Deferred Revenue stood at $124682.0 in 2020, then surged by 55.9% to $194376.0 in 2023, then skyrocketed by 113.51% to $415020.0 in 2024.
  • Business Quant data shows Current Deferred Revenue for AHG at $415020.0 in Q1 2024, $194376.0 in Q1 2023, and $124682.0 in Q1 2020.